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Objective: Results from studies examining associations between serum 25-
hydroxyvitamin D (25(OH)D) concentrations and depressive symptoms are equivocal. 
We investigated the relationship between serum 25(OH)D concentrations and symptoms 
of depression, anxiety and stress in a cross-sectional analysis of a population-based 
sample of young adults participating in the Western Australian Pregnancy Cohort 
(Raine) Study. Methods: Participants provided a blood sample at the 20 year follow-up 
(March 2010-April 2012) for the measurement of serum 25(OH)D concentrations. 
Mental health symptoms were assessed using the 21-item Depression Anxiety Stress 
Scales (DASS-21). Associations between serum 25(OH)D concentrations and total 
DASS-21 scores and subscale scores of depression, anxiety and stress were explored in 
males and females using negative binomial regression, adjusting for age, race, BMI and 
physical activity (n=735). Models examining subscale scores were also adjusted for the 
other subscale scores. Results: After adjusting for confounders, an increase in serum 
25(OH)D concentrations of 10 nmol/L decreased total DASS-21 scores in males by 9% 
(Rate Ratio 0.91; 95%CI 0.87,0.95; p<0.001) and depression subscale scores in males 
by 8% (Rate Ratio 0.92; 95%CI 0.87,0.96; p=0.001). However, in adjusted models there 
were no significant associations between serum 25(OH)D concentrations and symptoms 
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of anxiety and stress in males. There were no significant associations between serum 
25(OH)D concentrations and symptoms of depression, anxiety and stress in females. 
Conclusions: We found an association between serum 25(OH)D concentrations and 
symptoms of depression, but not anxiety and stress, in males. Randomised controlled 
trials are necessary to determine any benefit of vitamin D supplementation in the 
prevention and treatment of depressive symptoms in young adults. 
 
  




Vitamin D may play an important role in mood disorders. Vitamin D appears to be 
involved in brain function and it has been suggested that it acts as a neurosteroid (Eyles 
et al., 2005; Garcion et al., 2002; McGrath et al., 2001). Vitamin D metabolites can 
cross the blood-brain barrier and vitamin D receptors (VDR) have been identified in 
neuronal and glial cells in the central nervous system
 
(Eyles et al., 2005). Regions of the 
brain that are associated with the pathophysiology of mood disorders, such as the 
amygdala, hippocampus, hypothalamus and the dopaminergic neurons of the substantia 
nigra, carry VDR and 1α-hydroxylase – the enzyme responsible for converting 25-
hydroxyvitamin D (25(OH)D) into the active form of vitamin D (Drevets et al., 2008; 
Eyles et al., 2005). Mice lacking VDR have substantial behavioural impairment and 
increased anxiety compared with VDR-replete mice (Kalueff et al., 2006; Minasyan et 
al., 2007). Evidence from animal studies also supports a role of vitamin D in the 
expression of monoamines likely to be involved in depression, including 
norepinephrine, serotonin and dopamine (Cass et al., 2006; Garcion et al., 2002; Smith 
et al., 2006). 
 
A number of epidemiological studies have found associations between serum 25(OH)D 
concentrations and depression, independent of lifestyle and health factors (Ganji et al., 
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2010; Hoang et al., 2011; Jamilian et al., 2013; Kjaergaard et al., 2011; Lee et al., 2011; 
Milaneschi et al., 2010; Tolppanen et al., 2012). However, others have shown no 
association, including a large population-based study in the United States (Nanri et al., 
2009; Pan et al., 2009; Zhao et al., 2010). Many of these studies were conducted in 
middle-aged to elderly adults, with limited data available in young adults. Furthermore, 
serum 25(OH)D concentrations have not been widely examined in relation to anxiety 
and stress. We investigated the relationship between serum 25(OH)D concentrations 
and symptoms of depression, anxiety and stress in a cross-sectional analysis of a 
population-based cohort of young adults. It was hypothesised that low serum 25(OH)D 
concentrations would be associated with elevated depressive, anxiety and stress 
symptoms. 
 




The Western Australian Pregnancy Cohort (Raine) Study methodology has been 
described previously (Newnham et al., 1993). In brief, a total of 2900 pregnant women 
attending the public antenatal clinic at King Edward Memorial Hospital, or nearby 
private practices, were recruited into the Western Australian Pregnancy Cohort (Raine) 
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Study between May 1989 and November 1991. The criteria for enrolment were 
gestational age between 16 and 20 weeks, sufficient proficiency in English to 
understand the implications of participation, an expectation to deliver at the King 
Edward Memorial Hospital and an intention to remain in Western Australia in the 
coming years. Although 114 women delivered in hospitals other than the King Edward 
Memorial Hospital, their outcomes were still assessed. The vast majority (96%) gave 
birth at the King Edward Memorial Hospital. A total of 2868 children have undergone 
serial assessment at birth and at ages 1, 2, 3, 5, 8, 10, 14, 17 and 20 years. Recruitment 
was approved by the ethics committees of King Edward Memorial Hospital for Women 
and the Princess Margaret Hospital for Children, Perth, Western Australia and ethics 
approval at the 20 year follow-up was obtained from the University of Western 
Australia Human Research Ethics Committee. Informed and written consent was 
obtained from the participant and/or their primary caregiver for all follow-ups. 
 
Data collection for the 20 year follow-up occurred between March 2010 and April 2012. 
A total of 2125 young adults were eligible (not withdrawn or deferred) for follow-up at 
20 years. Of the 1565 who participated, 75% (n = 1172) provided a blood sample for 
measurement of serum 25(OH)D  concentrations and 78% (n = 1220) completed the 
DASS-21. Data for serum 25(OH)D concentrations and DASS-21 at 20 years were 
available for 945 participants. 
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Assessment of depression, anxiety and stress 
 
Mental health was assessed using the 21-item self-reported Depression Anxiety Stress 
Scales (DASS-21), which consists of three 7-item self-report scales that assess 
symptoms of depression, anxiety and stress (Lovibond et al., 1996). The longer DASS-
42 and short-form DASS-21 were developed using Australian data and have been 
validated in both clinical and non-clinical samples (Antony et al., 1998; Henry and 
Crawford, 2005; Ng et al., 2007). The depression scale assesses dysphoria, 
hopelessness, devaluation of life, self-deprecation, lack of interest/involvement, 
anhedonia, and inertia; the anxiety scale assesses autonomic arousal, skeletal muscle 
effects, situational anxiety, and subjective experience of anxious affect; and the stress 
scale assesses difficulty relaxing, nervous arousal, being easily upset/agitated, 
irritable/over-reactive and impatient. Participants were asked to rate the extent to which 
they had experienced each state over the past week on a four-point severity/frequency 
scale. Each item uses a 4-point response scale ranging from 0 (did not apply to me at 
all) to 3 (applied to me very much or most of the time). The DASS-21 yields separate 
depression, anxiety and stress subscale scores, and a total score that is the sum of the 
three subscales and represents a composite measure of negative emotional symptoms. 
Scores for each subscale can range from 0 to 21, with higher scores indicating greater 
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depression, anxiety or stress. The total score can range from 0 to 63. Cut-off scores 
defining mild/moderate/severe/extremely severe scores are designed for clinical practice 
and are not validated for research purposes; therefore, we used DASS-21 scores as a 
continuous measure.  
 
Assessment of serum 25(OH)D concentrations 
 
Participants provided a blood sample for measurement of serum 25(OH)D 
concentrations within two weeks of completing the DASS-21. Venous blood samples 
were taken from an antecubital vein after an overnight fast and samples were stored at -
80˚C until analysed using isotope-dilution liquid chromatography-tandem mass 
spectrometry (RDDT, Victoria, Australia), according to published methodology 
(Maunsell et al., 2005). Of the 945 participants who provided a blood sample and 
completed the DASS, only ten participants had detectable serum 25(OH)D2 
concentrations, ranging from 5.24 to 7.07 nmol/L. Given that blood samples were 
collected year-round between March 2010 and April 2012, and that an association 
between vitamin D levels and mental health symptoms would take time to develop, a 
sinusoidal model incorporating month of blood collection was used to calculate 
deseasonalised serum 25(OH)D3 concentrations (van der Mei et al., 2007). Since 
25(OH)D2 is obtained from food and supplements, rather than sunlight exposure, serum 
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25(OH)D2 concentrations were added to the deseasonalised serum 25(OH)D3 
concentrations to obtain total concentrations of serum 25(OH)D. We defined vitamin D 
levels as being sufficient when concentrations of serum 25(OH)D were ≥ 75 nmol/L, 
insufficient when they were 50-74.9 nmol/L and deficient when they were < 50 nmol/L 
(Holick et al., 2011). Duration of sun exposure, and vitamin D intakes from food and 
supplements, were not available at the 20 year follow-up. However, since serum 
25(OH)D concentrations are a product of sun exposure and dietary vitamin D intakes, 
these factors were accounted for by the measurement of serum 25(OH)D concentrations. 
 
Potential confounding variables 
 
Analyses were adjusted for variables that may confound the relationship between serum 
25(OH)D concentrations and symptoms of depression, anxiety and stress. Participants 
were classified as Caucasian if both parents were Caucasian, or as non-Caucasian if one 
or both parents were of an alternate ethnicity. Since the age of participants at the 20 year 
follow-up ranged from 19 to 22 years, we included age at date of blood sample as a 
potential confounder. Weight was measured to the nearest 100 g using Personal 
Precision scales UC-321 (A and D Company) and height was measured to the nearest 
0.1 cm with a wall mounted Seca 202. We calculated Body Mass Index (BMI) as weight 
in kilograms divided by height in metres squared. Physical activity was assessed by 
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asking participants how many days they engaged in moderate or vigorous physical 
activities of at least 10 minute duration during the last seven days. Responses were 
collapsed into three categories: exercises less than once per week, exercises 1-3 times 




Characteristics of participants who provided a blood sample for analysis of serum 
25(OH)D concentrations and completed the DASS-21 at the 20 year follow-up were 
compared with non-participants from the original cohort. Sex, race, family income 
during pregnancy, maternal age at birth, maternal education and maternal pre-pregnancy 
BMI were compared using Chi-square tests.  
 
Baseline characteristics, including age, race, deseasonalised serum 25(OH)D 
concentrations, vitamin D status, total DASS-21 scores and subscale scores, BMI  and 
physical activity were described for participants in the current study and stratified by 
sex. Chi-square tests were used to determine differences between males and females for 
categorical variables (race, deseasonalised serum 25(OH)D categories and physical 
activity). For continuous variables, skewness > 1 indicated that non-parametric analysis 
was appropriate. We used independent-samples t-tests to determine differences between 
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males and females in parametric data (deseasonalised serum 25(OH)D concentrations) 
and Mann-Whitney U tests for non-parametric data (age, total DASS-21 scores, DASS-
21 subscale scores and BMI).  
 
We performed univariate general linear models investigating the impact of potential 
confounding variables (age, race, BMI and physical activity) on serum 25(OH)D 
concentrations. Due to the highly skewed total DASS-21 scores and subscale scores, 
negative binomial regression with a log link was applied to investigate associations 
between serum 25(OH)D concentrations and DASS-21 scores (total score and 
depression, anxiety and stress subscale scores). Negative binomial regression reports a 
rate ratio, which is interpreted, in this case, as the predicted proportional increase in 
DASS scores per 10 nmol/L change in 25(OH)D concentrations. Models were 
performed unadjusted and then adjusted for sex, race, age, BMI and physical activity. 
Models examining subscale scores were also adjusted for the other subscale scores. An 
interaction term between sex and serum 25(OH)D concentrations was included to 
determine whether effects of serum 25(OH)D concentrations were different in males 
and females. Analyses were performed using IBM SPSS Statistics Release Version 
19.9.9.1 (IBM SPSS Inc., 2010, Chicago, IL). Statistical significance was defined as p < 
0.05.  
 





Compared with those from the original cohort who did not participate in the current 
study (n = 1923), participants in the current study (n = 945) were more likely to come 
from families with a higher income during pregnancy and to have mothers with a higher 
age, higher education and healthier body mass index (Table 1). There were no 
significant differences in sex and race between participants in the current study and non-
participants from the original cohort. 
 
In participants of the 20 year follow-up, the median (interquartile range, IQR) total 
DASS-21 score was 12 (20) for males and 18 (24) for females (Table 2) (p < 0.001). 
The median (IQR) scores for the depression subscale were 4 (8) for males and 4 (8) for 
females. For the anxiety subscale, the median (IQR) scores were 2 (6) for males and 4 
(8) for females. The median (IQR) scores for the stress subscale were 6 (10) for males 
and 8 (10) for females. The mean (standard deviation) serum 25(OH)D concentration 
was 70.7 (23.0) nmol/L for males and 74.8 (24.2) for females (p = 0.008). There was a 
significant difference in vitamin D status between males and females (p = 0.039). The 
prevalence of vitamin D deficiency (25(OH)D < 50 nmol/L) was 18% for males and 
12% for females. 
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Complete data, including all potential confounding variables, were available for 735 
participants. In univariate models, age, race, BMI and physical activity were all 
significantly associated with serum 25(OH)D concentrations (Table 3). When 
investigating the effect of serum 25(OH)D concentrations on total DASS-21 scores, 
there was a significant interaction between sex and serum 25(OH)D concentrations (p = 
0.005); therefore, models were stratified by sex. In unadjusted models, higher serum 
25(OH)D concentrations were significantly associated with decreased total DASS-21 
scores and all three subscale scores in males (Table 4). An increase of 10 nmol/L of 
serum 25(OH)D in males decreased total DASS-21 scores by 9% (Rate Ratio (RR) 
0.91; 95% CI 0.88, 0.96; p < 0.001), depression subscale scores by 12% (RR 0.88; 95% 
CI 0.83, 0.93; p < 0.001), anxiety subscale scores by 6% (RR 0.94; 95% CI 0.90, 0.99; p 
= 0.016) and stress subscale scores by 7% (RR 0.93; 95% CI 0.88, 0.97; p = 0.003).  
 
When adjusted for race, age, BMI and physical activity, the association between serum 
25(OH)D concentrations and total DASS-21 scores remained significant (RR 0.91; 95% 
CI 0.87, 0.95; p < 0.001). Similarly, when adjusted for race, age, BMI, physical activity, 
anxiety subscale score and stress subscale score, the association between serum 
25(OH)D concentrations and the depression subscale score remained significant (RR 
0.92; 95% CI 0.87, 0.96; p = 0.001). After adjusting for confounders, including the 
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depression subscale scores, there was no significant association between serum 
25(OH)D concentrations and symptoms of anxiety and stress in young adult males. In 
females, there were no significant associations between serum 25(OH)D concentrations 





Higher serum 25(OH)D concentrations were significantly associated with lower total 
DASS-21 scores and reduced symptoms of depression in males, after adjusting for age, 
race, BMI, physical activity, anxiety subscale scores and stress subscale scores. An 
advantage of using the DASS-21 is that it distinguishes between the related symptoms 
of depression, anxiety and stress. Our results suggest that vitamin D is related 
specifically to depressive symptoms, since we found no significant association between 
serum 25(OH)D concentrations and symptoms of anxiety and stress in males, after 
adjusting for confounders. Significant associations between serum 25(OH)D 
concentrations and symptoms of depression, anxiety and stress were not seen in 
females, either in unadjusted or adjusted models. These findings are important as 
relatively few studies have considered associations between vitamin D levels and 
symptoms of depression, anxiety and stress in young adults. 
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Several previous population-based studies in different age groups have examined the 
relationship between vitamin D levels and the presence of depressive symptoms (Ganji 
et al., 2010; Hoang et al., 2011; Jamilian et al., 2013; Kjaergaard et al., 2011; Lee et al., 
2011; Milaneschi et al., 2010; Nanri et al., 2009; Pan et al., 2009; Tolppanen et al., 
2012; Zhao et al., 2010). Kjaergaard et al. (2011) showed that low serum 25(OH)D 
concentrations predicted depressive symptoms in a cross-sectional study of adults aged 
30-87 years (n = 10,086) after adjusting for multiple confounders, including chronic 
disease. In concordance with our findings, there were no significant associations 
between low 25(OH)D concentrations and anxiety. Prospective analysis using data from 
the Avon Longitudinal Study of Parents and Children (ALSPAC) showed that higher 
concentrations of 25(OH)D3 were associated with lower levels of depressive symptoms 
in children (Tolppanen et al., 2012).  
 
Our findings differ from results of a large, cross-sectional, population-based study of 
adults aged ≥ 20 years in the United States (n = 3916) (Zhao et al., 2010). That study 
found inverse associations between vitamin D levels and moderate-to-severe depression 
after adjusting for age and sex, but the associations were not significant after adjusting 
for other potential confounders. A major confounder was the presence of chronic 
disease. Pan et al. (2009) also found no significant associations between vitamin D 
16 Wendy H. Oddy 
 
levels and depressive symptoms in 3262 Chinese adults aged 50-70 years after adjusting 
for potential confounders.  
 
Sex differences in the relationship between vitamin D levels and depression have been 
reported by Milaneschi et al. (2010) and Kjaergaard et al. (2011). In contrast to our 
findings, these studies reported stronger associations between serum 25(OH)D 
concentrations and depressive symptoms in females than males. A functional 
relationship between the active 1,25-dihydroxyvitamin D (1,25(OH)2D) and oestradiol 
has been suggested (Correale et al., 2010; Nashold et al., 2009), which may contribute 
to sex differences in response to low vitamin D levels. However, it is not clear why 
associations were evident in males and not females in the current study. The differences 
between males and females in response to serum 25(OH)D concentrations warrants 
further investigation in future studies. 
 
It is problematic to make comparisons between studies examining vitamin D levels and 
mental health due to the use of different tools to measure mental health symptoms and 
the use of different assays to determine circulating 25(OH)D concentrations. Circulating 
25(OH)D concentrations are measurable using several techniques, including 
competitive protein binding assay (CPBA), High Performance Liquid Chromatography 
(HPLC), radioimmunoassay (RIA) and enzyme immunoassay. However, there is 
17 Wendy H. Oddy 
 
significant variation in 25(OH)D measurement depending on the laboratory and assay 
used, confounding the diagnosis of vitamin D deficiency. Furthermore, baseline serum 
25(OH)D concentrations and season of blood collection differ between studies, and 
different confounders are used in statistical models. 
 
Results from clinical trials investigating vitamin D supplementation and depressive 
symptoms are varied (Bertone-Johnson et al., 2012; Dean et al., 2011; Dumville et al., 
2006; Hogberg et al., 20120; Jorde et al., 2008; Kjaergaard et al., 2012; Lansdowne et 
al., 1998; Sanders et al., 2011). Recently, a large, randomised, double-blinded trial in 
the United States, comprising 36,282 postmenopausal women, showed no relation 
between 400 IU/day vitamin D supplementation and depressive symptoms over a two-
year period (Bertone-Johnson et al., 2012). However, serum 25(OH)D concentrations 
were not available so it is not known whether the dose was sufficient to improve 
vitamin D status. Similarly, Kjaergaard et al. (2012) showed that although low levels of 
serum 25(OH)D were associated with depressive symptoms in adults, a high vitamin D 
dose of 40 000 IU/week for six months did not improve symptoms. In contrast, a cross-
sectional study of 441 adults in Norway found that a weekly vitamin D dose of 20 000 
IU significantly improved Beck Depression Inventory scores after one year (Jorde et al., 
2008). The equivocal results from vitamin D supplementation trials may be a reflection 
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of differences in dose, baseline 25(OH)D concentrations, latitude, race and the outcome 
measure of depressive symptoms. 
 
A strength of our study was the deseasonalisation of serum 25(OH)D concentrations, 
which is important since blood samples were collected year-round and vitamin D levels 
vary with respect to season of blood collection. A further strength was access to data 
that may influence both serum 25(OH)D concentrations and symptoms of depression, 
anxiety and stress, allowing us to adjust for potential confounders, including BMI and 
physical activity. This allowed us to examine the independent associations between 
serum 25(OH)D concentrations and the total DASS-21 scores and subscale scores. 
However, although we adjusted for physical activity, the measure of assessment was not 
based on a validated questionnaire and did not differentiate between indoor and outdoor 
activity.   
 
A limitation of our study was the use of self-reported questionnaire rather than clinical 
diagnosis to assess symptoms of depression, anxiety and stress. While self-report 
assessment has been established as a valid means for assessing mental health difficulties 
such as depression, anxiety and stress (Antony et al., 1998; Henry and Crawford, 2005) 
and may lead to more truthful reporting than face-to-face assessment, we cannot rule out 
the possibility of under- or over-reporting. Our results suggest an association between 
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serum 25(OH)D concentrations and self-reported depressive symptoms, rather than an 
association with a clinical diagnosis of depression.  
 
A further limitation of our study was the loss to follow-up. Participants included in the 
current study were more likely to be from families with higher socioeconomic status 
relative to participants from the original cohort and care should be taken when 
generalising results to the wider community. Furthermore, attrition may have been 
higher for those participants suffering from mental health symptoms, such as depression 
or anxiety. However, it should be possible to observe an association between vitamin D 
and mental health symptoms in the remaining participants, although the power to detect 
this association at a significant level may be weaker. 
 
Since the DASS-21 scores were only available at the 20 year follow-up, we conducted a 
cross-sectional analysis and do not infer a causative relationship between vitamin D 
levels and depressive symptoms in males. It is possible that males with depressive 
symptoms were less likely to engage in outdoor activities, leading to lower serum 
25(OH)D concentrations. Future follow-ups of the Raine cohort will likely provide 
mental health data based on the DASS-21, providing an opportunity for investigating 
the longitudinal association between serum 25(OH)D concentrations and the 
development of depressive symptoms. Furthermore, as the cumulative incidence of 
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depression increases in future follow-ups of the Raine cohort, it may be possible to 
investigate whether low vitamin D status impairs recovery from mental health disorders, 
including depression. This would be consistent with recent findings that daily vitamin D 





We found a cross-sectional association between serum 25(OH)D concentrations and 
symptoms of depression, but not anxiety and stress, in young adult males. In order to 
investigate a potential causative relationship between vitamin D levels and depressive 
symptoms, longitudinal investigations are warranted. Randomised controlled trials 
using effective doses of vitamin D, and monitoring serum 25(OH)D concentrations, are 
necessary to determine any benefit of vitamin D supplementation in the prevention and 
treatment of depression. 
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Table 1. Characteristics of participants (n = 945) v non-participants from the original 
cohort (n = 1923) 
  Participants   
Non-
participants   p 
  n (%)   n (%)     
Sex 
    
0.252 
     Male 465 (49.2) 990 (51.5) 
      Female 480 (50.8) 
 
933 (48.5) 
 Race  
   
0.079 










Family income per year during pregnancy 
    
< 0.001* 
     < $7,000 51 (5.4) 
 
178 (9.3) 
       $7,000-$11,999 57 (6.0) 
 
186 (9.7) 
       $12,000-$23,999 194 (20.5) 
 
489 (25.4) 
       $24,000-$35,999 231 (24.4) 
 
417 (21.7) 
       ≥ $36,000 365 (38.6) 
 
470 (24.4) 
       Unknown  
 
 
  Maternal age at birth  
   
< 0.001* 
     < 20 years 45 (4.8) 
 
233 (12.1) 
       20-24 years 165 (17.5) 
 
442 (23.0) 
       25-29 years 276 (29.2) 
 
578 (30.1) 
       30-34 years 289 (30.6) 
 
437 (22.7) 
       35-39 years 140 (14.8) 
 
160 (8.3) 
       ≥ 40 years 26 (2.8) 
 
37 (1.9) 
  Maternal education since school 
    
< 0.001* 
     None 401 (42.4) 
 
1047 (54.4) 
       Trade certificate or apprenticeship 67 (7.1) 
 
168 (8.7) 
       Professional registration (non-degree) 99 (10.5) 
 
147 (7.6) 
       College diploma or degree 162 (17.1) 
 
286 (14.9) 
       University degree 147 (15.6) 
 
133 (6.9) 
       Other 49 (5.2) 
 
98 (5.1) 
  Maternal pre-pregnancy BMI 
    
0.027* 
     Underweight (< 18.5) 89 (9.4) 
 
226 (11.8) 
       Healthy weight (18.5-24.9) 663 (70.2) 
 
1231 (64.0) 
       Overweight (25-29.9) 92 (9.7) 
 
221 (11.5) 
       Obese (≥ 30) 54 (5.7)   124 (6.4)     
BMI, body mass index; *Significant at p < 0.05 
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Table 2. Characteristics of the Raine Study participants for whom serum 25(OH)D concentrations and DASS-21 scores were available (n = 945) 
  Males   Females   p 
  n     n       
Age [years,  median (IQR)] 465 20.0 (0.5) 
 






    
0.570 
     Caucasian 389 83.7 
 
408 85.0 
       Other 76 16.3 
 
72 15.0 
  Serum 25(OH)D1 [nmol/L, mean (SD)] 465 70.7 (23.0) 
 
480 74.8 (24.2) 
 
0.008* 
DASS-21 [median (IQR)] 
            Total 465 12 (20) 
 
480 18 (24) 
 
< 0.001* 
     Depression scale 465 4 (8) 
 
480 4 (8) 
 
0.001* 
     Anxiety scale 465 2 (6) 
 
480 4 (8) 
 
0.012* 
     Stress scale 465 6 (10) 
 
480 8 (10) 
 
< 0.001* 
BMI [kg/m2,  median (IQR)] 460 23.5 (4.8) 
 
471 23.0 (5.2) 
 
0.092 
Physical activity (%) 
      
< 0.001* 
     ≥ 4 times per week 330 73.2 
 
223 47.2
       1-3 times per week 73 16.2 
 
142 30.1 
       < once per week 48 10.6   107 22.7     
 
25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; DASS-21, 21-item Depression Anxiety Stress Scales; IQR, interquartile range; SD, 
standard deviation 
Vitamin D status: deficient, 25(OH)D < 50 nmol/L; insufficient, 25(OH)D 50-74.9 nmol/L; sufficient, 25(OH)D ≥ 75 nmol/L 
 
1
Deseasonalised serum 25(OH)D concentrations; *Significant difference between males and females (p < 0.05) 
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Table 3. Unadjusted general linear models showing the effect of potential confounding factors 
on deseasonalised serum 25(OH)D concentrations (n = 735) 
 
*Significant at p < 0.05 
  
β (95% CI) p
Age (per year) -4.27 (-8.39, -0.15) 0.042*
Race
     Non-Caucasian Ref.
     Caucasian 14.563 (9.76, 19.37) <0.001*
Body mass index (per kg/m
2
) -0.91 (-1.25, -0.57) <0.001*
Physical activity
     ≥ 4 times per week Ref.
     1-3 times per week -6.14 (-10.33, -1.95) 0.004*
     < once per week -7.83 (-12.53, -3.14) 0.001*
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Table 4. Unadjusted and adjusted negative binomial model coefficients for the effect of 
deseasonalised serum 25(OH)D concentrations (per increase of 10 nmol/L) on DASS-21 
scores and subscale scores in males and females 
  Males (n = 353)   Females (n = 382) 
DASS-21 
Rate Ratio (95% 





Total 0.91 (0.88, 0.96) <0.001* 
 
0.99 (0.95, 1.03) 0.594 
Depression 0.88 (0.83, 0.93) <0.001* 
 
0.97 (0.92, 1.02) 0.174 
Anxiety 0.94 (0.90, 0.99) 0.016* 
 
0.99 (0.94, 1.04) 0.719 
Stress 0.93 (0.88, 0.97) 0.003* 
 





Total 0.91 (0.87, 0.95) <0.001* 
 
1.00 (0.96, 1.04) 0.915 
Depression 0.92 (0.87, 0.96) 0.001* 
 
0.99 (0.95, 1.03) 0.515 
Anxiety 1.02 (0.98, 1.07) 0.343 
 
0.99 (0.95, 1.03) 0.484 
Stress 0.98 (0.94, 1.03) 0.429   1.02 (0.98, 1.05) 0.332 
 




Adjusted for race, age, BMI and physical activity - models using the DASS-21 
subscale scores were adjusted for the other subscale scores  
*Significant at p < 0.05 
 
 
